The global high tibial osteotomy plates market size was US$ 311.06 million in 2021. The global high tibial osteotomy plates market size is forecast to reach US$ 400.3 million by 2030, growing at a ...

Amplitude beat estimates in its second-quarter earnings report. Revenue growth has accelerated for three quarters in a row and is expected to improve in the third quarter. A trio of recent ...

A rare and aggressive type of brain cancer that often becomes fatal a year after its diagnosis in children and young adults now has its first FDA-approved therapy, a once-weekly capsule from Jazz ...

Amplitude Inc (NASDAQ:AMPL) reported strong Q2 2025 results with revenue of $83.3 million, up 14% year over year, exceeding the high end of their guidance. Annual recurring revenue (ARR) increased to ...

Modeyso is the first FDA-approved treatment for recurrent H3 K27M-mutant diffuse midline glioma, offering a new option for patients with limited choices. Phase II trials showed a 22% objective ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Modeyso for patients with H3 K27M-mutant diffuse midline glioma. The therapy showed an overall ...

What Is Modeyso, and Why Does It Matter? Modeyso (dordaviprone) is a new oral medicine that treats a rare and aggressive brain tumor, called diffuse midline glioma (DMG), that has a tumor mutation ...

Actor Kelley Mack, who was best known for playing Addy on the TV show "The Walking Dead," died at age 33 on Aug. 2, 2025, her sister announced in an Instagram post. Following the announcement, some ...

H3 K27M-mutant diffuse midline glioma is a rare and highly aggressive brain tumour. Credit: Dmytro Zinkevych/Shutterstock.com. The US Food and Drug Administration (FDA) has given accelerated approval ...

The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with diffuse midline glioma harboring H3 K27M mutations. Labeling stipulates use in ...

Kelley Mack was said to be suffering from Diffuse midline glioma (DMG), which is a rare and aggressive brain tumor, which affects children and young adults. This malignant tumor develops within the ...

Aug 6 (Reuters) - The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' (JAZZ.O), opens new tab drug to treat diffuse midline glioma, a rare and aggressive ...